Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Description

The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.

Conditions

Endocervical Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Condition
Endocervical Cancer
Intervention / Treatment

-

Contacts and Locations

Little Rock

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female, ≥ 18 years of age
  • * Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy
  • * Able to provide written consent
  • * Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound
  • * History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras
  • * Known history of elevated intraocular pressure
  • * Claustrophobia, thalassophobia, cleithrophobia or similar phobias
  • * Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Arkansas,

Gary Lewis, MD, PRINCIPAL_INVESTIGATOR, University of Arkansas

Study Record Dates

2026-12